115 related articles for article (PubMed ID: 35459373)
21. Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review.
Chan K; Sharif S; Rochwerg B
CJEM; 2021 Mar; 23(2):159-161. PubMed ID: 33534117
[No Abstract] [Full Text] [Related]
22. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
[TBL] [Abstract][Full Text] [Related]
23. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.
Mehta P; Gasparyan AY; Zimba O; Kitas GD
Clin Rheumatol; 2022 Sep; 41(9):2893-2910. PubMed ID: 35639259
[TBL] [Abstract][Full Text] [Related]
24. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia.
Nasrallah S; Nguyen AQ; Hitchings L; Wang JQ; Hamade S; Maxwell GL; Khoury A; Gomez LM
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5970-5977. PubMed ID: 33771091
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone for COVID-19: preliminary findings.
Drug Ther Bull; 2020 Sep; 58(9):133. PubMed ID: 32690491
[No Abstract] [Full Text] [Related]
27. Efficacy of synthetic glucocorticoids in COVID-19 endothelites.
Ferrara F; Vitiello A
Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):1003-1007. PubMed ID: 33443616
[TBL] [Abstract][Full Text] [Related]
28. Use of glucocorticoids and azithromycin in the therapy of COVID-19.
de Lemos Neto M; Alexandre RCV; Morra ROG; da Paz JAS; Barroso SPC; Resende AC; de Medeiros-Lima DJM; Alexandre PCB
Pharmacol Rep; 2021 Dec; 73(6):1513-1519. PubMed ID: 34085181
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia.
Pontali E; Volpi S; Signori A; Antonucci G; Castellaneta M; Buzzi D; Montale A; Bustaffa M; Angelelli A; Caorsi R; Giambruno E; Bobbio N; Feasi M; Gueli I; Tricerri F; Calautti F; Castagnola E; Moscatelli A; Rollandi GA; Ravelli A; Cassola G; Sormani MP; Gattorno M
J Allergy Clin Immunol; 2021 Apr; 147(4):1217-1225. PubMed ID: 33556464
[TBL] [Abstract][Full Text] [Related]
30. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
31. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
Guimarães PO; Quirk D; Furtado RH; Maia LN; Saraiva JF; Antunes MO; Kalil Filho R; Junior VM; Soeiro AM; Tognon AP; Veiga VC; Martins PA; Moia DDF; Sampaio BS; Assis SRL; Soares RVP; Piano LPA; Castilho K; Momesso RGRAP; Monfardini F; Guimarães HP; Ponce de Leon D; Dulcine M; Pinheiro MRT; Gunay LM; Deuring JJ; Rizzo LV; Koncz T; Berwanger O;
N Engl J Med; 2021 Jul; 385(5):406-415. PubMed ID: 34133856
[TBL] [Abstract][Full Text] [Related]
32. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
[TBL] [Abstract][Full Text] [Related]
33. Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study.
Kuo KC; Chen CH; Wang CJ; Wu JC; Chung HP; Chen YT; Tang YH; Chang WK; Lin CY; Wu CL
BMC Pulm Med; 2022 Sep; 22(1):368. PubMed ID: 36171597
[TBL] [Abstract][Full Text] [Related]
34. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
35. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases.
Iwabuchi K; Yoshie K; Kurakami Y; Takahashi K; Kato Y; Morishima T
J Infect Chemother; 2020 Jun; 26(6):625-632. PubMed ID: 32362440
[TBL] [Abstract][Full Text] [Related]
37. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani S; Crisafulli S; Giorgi Rossi P; Mancuso P; Salvarani C; Atzeni F; Gini R; Kirchmayer U; Belleudi V; Kurotschka PK; Leoni O; Ludergnani M; Ferroni E; Baracco S; Massari M; Trifirò G;
Rheumatology (Oxford); 2021 Oct; 60(SI):SI25-SI36. PubMed ID: 33856453
[TBL] [Abstract][Full Text] [Related]
38. Multi-Omics Reveals Mechanisms of Partial Modulation of COVID-19 Dysregulation by Glucocorticoid Treatment.
Spick M; Campbell A; Baricevic-Jones I; von Gerichten J; Lewis HM; Frampas CF; Longman K; Stewart A; Dunn-Walters D; Skene DJ; Geifman N; Whetton AD; Bailey MJ
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292938
[TBL] [Abstract][Full Text] [Related]
39. International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.
Weber GM; Zhang HG; L'Yi S; Bonzel CL; Hong C; Avillach P; Gutiérrez-Sacristán A; Palmer NP; Tan ALM; Wang X; Yuan W; Gehlenborg N; Alloni A; Amendola DF; Bellasi A; Bellazzi R; Beraghi M; Bucalo M; Chiovato L; Cho K; Dagliati A; Estiri H; Follett RW; García Barrio N; Hanauer DA; Henderson DW; Ho YL; Holmes JH; Hutch MR; Kavuluru R; Kirchoff K; Klann JG; Krishnamurthy AK; Le TT; Liu M; Loh NHW; Lozano-Zahonero S; Luo Y; Maidlow S; Makoudjou A; Malovini A; Martins MR; Moal B; Morris M; Mowery DL; Murphy SN; Neuraz A; Ngiam KY; Okoshi MP; Omenn GS; Patel LP; Pedrera Jiménez M; Prudente RA; Samayamuthu MJ; Sanz Vidorreta FJ; Schriver ER; Schubert P; Serrano Balazote P; Tan BW; Tanni SE; Tibollo V; Visweswaran S; Wagholikar KB; Xia Z; Zöller D; ; Kohane IS; Cai T; South AM; Brat GA
J Med Internet Res; 2021 Oct; 23(10):e31400. PubMed ID: 34533459
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial.
Clemency BM; Varughese R; Gonzalez-Rojas Y; Morse CG; Phipatanakul W; Koster DJ; Blaiss MS
JAMA Intern Med; 2022 Jan; 182(1):42-49. PubMed ID: 34807241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
